People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...

The latest force torque sensors provide the levels of sensitivity and reliability needed for industrial cobot applications.

Abstract: This paper discusses the numerical analysis and optimisation of a conventional air-cooled heat sink having an insignificant geometrical modification to reduce the temperature gradient of ...

Though post-apocalyptic stories have become an expectation in the film and TV industry, Vice Gilligan‘s 2025 sci-fi, Pluribus, pushes the boundaries. Set in his favorite setting, Albuquerque, New ...

What’s one thing every leader can do to make sure employees are happy at work and engaged with their jobs? Make sure they can trust in you, your organization, and one another. That’s the finding in a ...

A study by the Ministry of New & Renewable Energy (MNRE) shows that India’s cumulative potential for solar power is more than 3,300 gigawatts (GW), compared to the government’s 2014 projection of ...

Sure, the kickoff on Thursday night is an incredible scene, and having NFL football on television is great, but nothing — with all due respect to my friends and family and loved ones — compares to ...

Some reassuring news for patients taking GLP-1 receptor agonists: Concerns that the drugs may cause retinopathy may be overblown. A new analysis of nearly 160,000 people with diabetes taking four ...

A phase 1/2 dose escalation study of the oral DNA polymerase theta inhibitor (POLQi) GSK4524101 ± niraparib in adults with advanced or metastatic solid tumors. This is an ASCO Meeting Abstract from ...

Abstract: In this work, we discuss the design and development of an ultra-high sensitivity imaging system, Coded Sensing SPECT (CS-SPECT), dedicated to guide and ...

Aon researchers found that within two years, improved health outcomes for patients who were taking GLP-1 drugs lowers the growth rate of medical care costs. Aon looked at medical claims data for ...

SAN DIEGO--(BUSINESS WIRE)--Alterome Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the development of next-generation, small molecule targeted therapies for the treatment ...